Trademarkia Logo

Canada

C$
Trademark Search in Canada
ZYLORION

View On IC.GC.CA

ZYLORION
SEARCHED

on 24 Jan 2025

Last Applicant/ Owned by

PsiloTec Health Solutions Inc.

855 2nd Street S.W., Suite 3500Calgary

ALBERTA

CA

T2P4J8

Serial Number

2137617 filed on 4th Oct 2021

Correspondent Address

BLAKE, CASSELS & GRAYDON LLP

INTELLECTUAL PROPERTY GROUPSUITE 4000, COMMERCE COURT WEST199 BAY STREETTORONTO

ONTARIO

CA

M5L1A9

ZYLORION

Trademark usage description

psychedelic medicines for the treatment of psychiatric diseases, namely mood disorders, depression, mood and emotional instability disorders; psychede Read More

Classification Information

Class [005]
Psychedelic medicines for the treatment of psychiatric diseases, namely mood disorders, depression, mood and emotional instability disorders; psychedelic medicines for the treatment of addiction disorders, namely alcohol abuse, drug abuse, eating disorders, gambling addiction and sex addiction; psychedelic medicines for the treatment of anxiety disorders, namely social anxiety, generalized anxiety and panic attack disorder; psychedelic medicines for the treatment of psychological trauma, namely post-traumatic stress disorder, occupational stress injury, bullying, emotional trauma, physical trauma, work trauma, family violence and grief; psychedelic medicines for the treatment of physical trauma, namely post-burn injury, post-spinal-cord injury, adult post-amputation, post-brain injury and post-stroke; psychedelic medicines for the treatment of chronic pain, namely migraines, chronic back pain and chronic arthritis; psychedelic medicines for the treatment of cognitive diseases, namely cognitive deterioration, early dementia and age-associated memory impairment; psychedelic medicines for the treatment of neuropsychiatric disorders, namely adult fetal alcohol spectrum disorder, adult attention deficit disorder, adult autism, post-stroke symptoms, multiple sclerosis and Parkinson's disease; psychedelic medicines for the treatment of sleep related disorders, namely chronic fatigue syndrome, fatigue and insomnia; psychedelic medicines for the treatment of mental health problems experienced by indigenous and other marginalized communities; psychedelic medicines for the treatment of covid-19 symptoms and syndromes

Classification kind code

11

Class [009]
Computer application software for mobile phones for providing therapy services to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; Downloadable computer software for providing therapy services to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

Classification kind code

11

Class [029]
Dried edible mushrooms

Classification kind code

11

Class [031]
Fresh edible mushrooms

Classification kind code

11

Class [035]
Compilation and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

Classification kind code

11

Class [041]
Provision of education and training in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of education and training in the field of psychedelic medicines

Classification kind code

11

Class [042]
Medical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; laboratory research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; non-downloadable computer software for providing therapy services to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

Classification kind code

11

Class [044]
Psychotherapy services; therapy for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services

Classification kind code

11

Mark Details

Serial Number

2137617

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 24th Jan 2025		Search Recorded
Submitted for opposition 20
on 24th Jan 2025		Examiner's First Report
Submitted for opposition 287
on 8th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 4th Oct 2021		Filed
Submitted for opposition 1
on 4th Oct 2021		Created
Submitted for opposition 31
on 4th Oct 2021		Formalized